Sean A. McCarthy, CEO: CytomX Therapeutics CTMX Sell · Filed 24/08/22

Trade details

Type: Insider sale
Amount: $17,094.54
Shares · price: 13,898 sh · $1.23 a share
Held after: 657,851 sh
Stock: CytomX Therapeutics CTMX
Person: Sean A. McCarthyCEO
Trade date: 24/08/20
Filed: 24/08/22
Days to filing: 2 days

Sold 2.1% of holdings

Share of holding sold: 2.1%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/21~24/09/19

Sean A. McCarthy's recent trades

Sean A. McCarthyCEO
Sell10b5-1 planCytomX Therapeutics
Sell10b5-1 plan
CytomX Therapeutics
CTMX
$763.8K
118,969 sh
$763.8K
Filed 03/19
Traded 03/17
Sean A. McCarthyCEO
Sell10b5-1 planCytomX Therapeutics
Sell10b5-1 plan
CytomX Therapeutics
CTMX
$462.1K
101,793 sh
$462.1K
Filed 25/11/10
Traded 25/11/06
Sean A. McCarthyCEO
Planned sale10b5-1 planCytomX Therapeutics
Planned sale10b5-1 plan
CytomX Therapeutics
CTMX
$461.9K
101,793 sh
$461.9K
Filed 25/11/06
Traded 25/11/06
Sean A. McCarthyCEO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$149.3K
55,511 sh
$149.3K
Filed 25/06/17
Traded 25/06/16
Sean A. McCarthyCEO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$22.6K
37,656 sh
$22.6K
Filed 25/03/20
Traded 25/03/18